Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Toplak

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Journal of Hypertension|April 11, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatmentVasilios Kotsis, Jens Jordan, Dragan Micic, et al.
International Journal of Cardiology|March 18, 2015
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality riskAndreas Tomaschitz, Stefan Pilz, Jutta Rus-Machan, et al.
Journal of Hypertension|April 14, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directionsVasilios Kotsis, Konstantinos Tsioufis, Christina Antza, et al.
Journal of the American College of Cardiology|September 1, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT TrialBenjamin M Scirica, A Michael Lincoff, Ildiko Lingvay, et al.
Wiener Klinische Wochenschrift|March 12, 2014
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular riskGerald Klose, Frank Ulrich Beil, Hans Dieplinger, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Insulin therapy of type 2 diabetes mellitus (Update 2019)]Monika Lechleitner, Martin Clodi, Heidemarie Abrahamian, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|October 11, 2023
[Overweight and obesity in adults: general principles of treatment and conservative management]Johanna Maria Brix, Barbara Andersen, Kadriye Aydinkoc-Tuzcu, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)]Martin Clodi, Heidemarie Abrahamian, Felix Aberer, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Hypertension|April 11, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatmentVasilios Kotsis, Jens Jordan, Dragan Micic, et al.
International Journal of Cardiology|March 18, 2015
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality riskAndreas Tomaschitz, Stefan Pilz, Jutta Rus-Machan, et al.
Journal of Hypertension|April 14, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directionsVasilios Kotsis, Konstantinos Tsioufis, Christina Antza, et al.
Journal of the American College of Cardiology|September 1, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT TrialBenjamin M Scirica, A Michael Lincoff, Ildiko Lingvay, et al.
Wiener Klinische Wochenschrift|March 12, 2014
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular riskGerald Klose, Frank Ulrich Beil, Hans Dieplinger, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Insulin therapy of type 2 diabetes mellitus (Update 2019)]Monika Lechleitner, Martin Clodi, Heidemarie Abrahamian, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)]Martin Clodi, Heidemarie Abrahamian, Helmut Brath, et al.
Wiener Klinische Wochenschrift|October 11, 2023
[Overweight and obesity in adults: general principles of treatment and conservative management]Johanna Maria Brix, Barbara Andersen, Kadriye Aydinkoc-Tuzcu, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)]Martin Clodi, Heidemarie Abrahamian, Felix Aberer, et al.
Pageof 8